In 2021, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs that are either New Molecular Entity (NME) under New Drug Application
/PRNewswire/ The "Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge,.
/PRNewswire/ The "Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge,.
On September 10, 2021, Janet Woodcock, Acting Commissioner of the U.S. Food and Drug Administration (FDA), sent a letter to Andrew Hirshfeld, Director of the U.S. Patent and Trademark.